Large Molecule Bioanalysis done differently

To help you achieve more.

We are a bioanalytical lab that has evolved the model for partnership in large molecule bioanalysis to benefit our customers and the patients they serve.

Services Delivered Scientist to Scientist

Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.






Pharmacokinetics (PK)


Cell-Based Assays

Solutions Enabled by World-Leading Expertise

Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.




Gene Therapy


Antibody Drug Conjugates (ADCs)



gene therapy webinar

immunogenicity of gene therapies

Immunogenicity Assessment of Gene Therapy Compounds: Discussion on Current and Future Concepts

Co-Hosted with Bioanalysis Zone

What is particular to the immunogenicity of gene therapies as compared to other biologic drugs? Which immunogenicity assessments are recommended from the scientific point of view? BioAgilytix’s experts Dr. Arno Kromminga and Dr. Lydia Michaut address these questions and more.

Access Recording

The Bioagilytix Perspective

Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.

resource center

Visit Resource Center

usa europe labs

Advanced bioanalytical lab facilities to support all phases of large molecule global studies.

    LinkedIn Company Updates

  • 3 Days Agoview on linkedin


    Last month at WRIB, our scientific team had the opportunity to participate in a number of discussions surrounding the latest topics of interest in biomarkers, immunogenicity, and regulatory standards. We wanted to share some of the event takeaways we found most interesting and valuable:

  • 3 Days Agoview on linkedin


    Do you have a problematic assay other CROs can’t crack? Speak with one of our scientists today and learn how we’ll take on your rescue project to get it back on track, fast and with accurate results:

  • 4 Days Agoview on linkedin


    The FDA recently published a guidance to help sponsors demonstrate that a proposed therapeutic protein product is interchangeable with a reference product, discussing the type and amount of data needed to support interchangeability. Do you know what these considerations entail? Read BioPharm International for more:

global map

Advancing Bioanalytical Excellence Internationally

Choose a Location to learn more about the premier bioanalytical services and solutions available at each of our advanced laboratories in the USA and Europe.